再生不良性貧血(Aplastic Anemia):世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

【英文タイトル】Aplastic Anemia Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Aplastic Anemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Aplastic Anemia to Hematological Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Aplastic Anemia to Hematological Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Aplastic Anemia 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Aplastic Anemia Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Miltenyi Biotec GmbH 35
Clinical Trial Overview of Miltenyi Biotec GmbH 35
Pluristem Therapeutics Inc. 36
Clinical Trial Overview of Pluristem Therapeutics Inc. 36
Mitsubishi Chemical Holdings Corporation 37
Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 37
Merck & Co., Inc. 38
Clinical Trial Overview of Merck & Co., Inc. 38
Kyowa Hakko Kirin Co., Ltd. 39
Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 39
Cephalon, Inc. 40
Clinical Trial Overview of Cephalon, Inc. 40
BioLineRx, Ltd. 41
Clinical Trial Overview of BioLineRx, Ltd. 41
Bharat Serums And Vaccines Limited 42
Clinical Trial Overview of Bharat Serums And Vaccines Limited 42
Clinical Trial Overview of Top Institutes / Government 43
National Heart, Lung, and Blood Institute 43
Clinical Trial Overview of National Heart, Lung, and Blood Institute 43
University of Texas M. D. Anderson Cancer Center 45
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 45
Roswell Park Cancer Institute 46
Clinical Trial Overview of Roswell Park Cancer Institute 46
University of California, San Francisco 47
Clinical Trial Overview of University of California, San Francisco 47
Asan Medical Center 48
Clinical Trial Overview of Asan Medical Center 48
Chinese Academy of Medical Sciences and Peking Union Medical College 49
Clinical Trial Overview of Chinese Academy of Medical Sciences and Peking Union Medical College 49
Emory University 50
Clinical Trial Overview of Emory University 50
Baylor College of Medicine 51
Clinical Trial Overview of Baylor College of Medicine 51
University of Chicago 52
Clinical Trial Overview of University of Chicago 52
City of Hope 53
Clinical Trial Overview of City of Hope 53
Five Key Clinical Profiles 54
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82


【レポート販売概要】

■ タイトル:再生不良性貧血(Aplastic Anemia):世界の治験レビュー2014年下半期版
■ 英文:Aplastic Anemia Global Clinical Trials Review, H2, 2014
■ 発行日:2014年12月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2507CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。